Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a ...

Viatris Inc. today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The ...

The drug is currently in Phase II stage of clinical trial evaluation to treat IPF. LYT-100: PureTech LYT-100 is PureTech's ...

It is powered by a 1.2-litre three-cylinder petrol engine available in two configurations: the naturally aspirated Puretech 82 engine producing 80 bhp and 115 Nm of torque, and the turbocharged ...

The Citroen Aircross Xplorer Edition is available in two packages: Standard and Optional, priced at ₹24,000 and ₹51,700, ...

Bristol Myers Squibb (NYSE:BMY) said its newly approved schizophrenia therapy, Cobenfy, improved disease symptoms with a well ...

Inspired by the legendary ‘60s Fulvia Coupé HF, with which it shares its front-wheel-drive configuration, reduced dimensions, ...

Blueprint Medicines Corporation today reported financial results, provided a business update for the third quarter ended Sept 30, 2024, and ...

UBS Global Healthcare Conference Presenters: Bharatt Chowrira, Ph.D., J.D., Chief Executive Officer, and Eric Elenko, Ph.D., Co-founder and President Date: Wednesday, November 13, 2024 Time: 8:45 a.m.

Cambridge, MA, October 28, 2024 –Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence ...

The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform originally developed by Monash University, has announced the closing of an oversubscribed ...